Consumption of psychoactive substances in prison: Between initiation and improvement, what trajectories occur after incarceration? COSMOS study data.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
29
04
2019
accepted:
30
10
2019
entrez:
5
12
2019
pubmed:
5
12
2019
medline:
1
4
2020
Statut:
epublish
Résumé
Few studies have examined the consumption trajectories of inmates after entry to prison. The aim of this study was to assess the changes in the consumption of psychoactive substance between the period before detention and during incarceration and to characterize the profiles of prisoners with similar consumption trajectories during incarceration. A multicenter, cross-sectional study was performed in all of the prisons from one region of France. All prisoners incarcerated during their 3rd months, over 18 years old, and with a sufficient level of French fluency to participate in the study were recruited over a period of 12 months. A total of 800 prisoners were recruited. All prisoners were interviewed face-to-face by a trained interviewer. A majority of prisoners had used at least one psychoactive substance in the weeks prior to incarceration. During incarceration, a substantial reduction in alcohol and illicit drug consumption was observed. The initiation of consumption and an increase in consumption were primarily related to medications. Five different profiles of consumption before incarceration were identified. These profiles all had a high probability of migrating to a similar profile during detention, characterized by less severe consumption of psychoactive substances. Based on their consumption profile prior to incarceration, most prisoners would benefit from a specific medical evaluation as soon as possible following entry into detention. Prison could be an opportunity for reduced consumption and/or the initiation of treatment for the majority of prisoners, despite the pejorative development observed for a minority of prisoners during incarceration.
Sections du résumé
BACKGROUND
Few studies have examined the consumption trajectories of inmates after entry to prison. The aim of this study was to assess the changes in the consumption of psychoactive substance between the period before detention and during incarceration and to characterize the profiles of prisoners with similar consumption trajectories during incarceration.
METHODS AND FINDINGS
A multicenter, cross-sectional study was performed in all of the prisons from one region of France. All prisoners incarcerated during their 3rd months, over 18 years old, and with a sufficient level of French fluency to participate in the study were recruited over a period of 12 months. A total of 800 prisoners were recruited. All prisoners were interviewed face-to-face by a trained interviewer. A majority of prisoners had used at least one psychoactive substance in the weeks prior to incarceration. During incarceration, a substantial reduction in alcohol and illicit drug consumption was observed. The initiation of consumption and an increase in consumption were primarily related to medications. Five different profiles of consumption before incarceration were identified. These profiles all had a high probability of migrating to a similar profile during detention, characterized by less severe consumption of psychoactive substances.
CONCLUSIONS
Based on their consumption profile prior to incarceration, most prisoners would benefit from a specific medical evaluation as soon as possible following entry into detention. Prison could be an opportunity for reduced consumption and/or the initiation of treatment for the majority of prisoners, despite the pejorative development observed for a minority of prisoners during incarceration.
Identifiants
pubmed: 31800580
doi: 10.1371/journal.pone.0225189
pii: PONE-D-19-12139
pmc: PMC6892542
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0225189Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Addiction. 2009 Jul;104(7):1233-40
pubmed: 19426291
Cien Saude Colet. 2016 Jun;21(7):2081-8
pubmed: 27383342
Drug Alcohol Rev. 2018 Apr;37 Suppl 1:S268-S276
pubmed: 29105203
Encephale. 2010 Apr;36(2):122-31
pubmed: 20434629
Addiction. 2009 Feb;104(2):215-22
pubmed: 19149815
BMC Public Health. 2011 May 27;11:400
pubmed: 21619573
Addiction. 2006 Feb;101(2):181-91
pubmed: 16445547
BMC Psychiatry. 2006 Aug 21;6:33
pubmed: 16923177
Rev Epidemiol Sante Publique. 2006 Jul;54 Spec No 1:1S53-1S59
pubmed: 17073130
Subst Abuse Treat Prev Policy. 2007 Jan 04;2:1
pubmed: 17204156
Rev Epidemiol Sante Publique. 2017 Sep;65(5):361-367
pubmed: 28886958
Rev Epidemiol Sante Publique. 2012 Oct;60(5):371-81
pubmed: 22981309
J Sleep Res. 2017 Jun;26(3):322-329
pubmed: 28239925
Lancet Infect Dis. 2009 Jan;9(1):57-66
pubmed: 19095196
BMC Public Health. 2017 Apr 20;17(1):342
pubmed: 28427371
Soc Sci Med. 1994 Dec;39(11):1585-6
pubmed: 7817222
Lancet. 2016 Sep 17;388(10050):1202-14
pubmed: 27427457
Therapie. 2016 Sep;71(4):375-8
pubmed: 27296806
Gac Sanit. 2015 Sep-Oct;29(5):358-63
pubmed: 26228003
Glob Public Health. 2017 Feb;12(2):170-184
pubmed: 26465257
Subst Use Misuse. 2006;41(10-12):1603-21
pubmed: 17002994
Euro Surveill. 2013 Jul 11;18(28):null
pubmed: 23870097
Therapie. 2011 May-Jun;66(3):263-72
pubmed: 21819810
Prev Sci. 2013 Apr;14(2):157-68
pubmed: 21318625
Int J Prison Health. 2015;11(1):17-29
pubmed: 25751704
Sante Publique. 2006 Jun;18(2):223-34
pubmed: 16886546
Presse Med. 2012 Jul;41(7-8):e375-85
pubmed: 22386285
Aust Nurs Midwifery J. 2016 Dec;24(6):39
pubmed: 29251892
Can J Public Health. 2014 May 09;105(3):e198-202
pubmed: 25165839
AMA J Ethics. 2017 Sep 1;19(9):922-930
pubmed: 28905733
Therapie. 2015 Mar-Apr;70(2):113-31
pubmed: 25858567
Lancet Psychiatry. 2017 Dec;4(12):946-952
pubmed: 29179937